CP-810123
Code | Size | Price |
---|
TAR-T31079-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T31079-50mg | 50mg | £1,661.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T31079-100mg | 100mg | £2,079.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Images
Documents
Further Information
Bioactivity:
CP-810123 is a new alpha 7 NAChR agonist with the potential for the treatment of cognitive deficits associated with psychiatric or neurological disorders such as schizophrenia and Alzheimer's disease.
CAS:
439608-12-5
Formula:
C14H18N4O
Molecular Weight:
258.325
Purity:
0.98
SMILES:
Cc1ccc2oc(nc2n1)N1CCN2CCC1CC2
References
1. O'Donnell CJ, Rogers BN, Bronk BS,et al. Discovery of 4-(5-methyloxazolo[4,5-b]pyridin-2-yl)-1,4-diazabicyclo[3.2.2]nonane (CP-810,123), a novel alpha 7 nicotinic acetylcholine receptor agonist for the treatment of cognitive disorders in schizophrenia: synthesis, SAR development, and in vivo efficacy in cognition models. J Med Chem. 2010 Feb 11;53(3):1222-37. doi: 10.1021/jm9015075. PubMed PMID: 20043678.